Invokana (in-vo-KAHN-uh, canagliflozin), as the first in a new class of oral drugs for type 2 diabetes

July 2014

Reps will promote Invokana (in-vo-KAHN-uh, canagliflozin), as the first in a new class of oral drugs for type 2 diabetes.

You'll hear it referred to as an "SGLT2 inhibitor"...because it inhibits sodium-glucose co-transporter 2 in the kidneys.

This allows more glucose to spill into the urine instead of being reabsorbed.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Infectious Diseases Summer brings questions about how to manage tick bites
Diabetes Invokana (in-vo-KAHN-uh, canagliflozin), as the first in a new class of oral drugs for type 2 diabetes
Diabetes Insulin errors are leading to emergency visits and poor outcomes
Infectious Diseases how they can avoid getting Middle East Respiratory Syndrome (MERS)
Constipation Constella (con-STEL-la) for chronic constipation or irritable bowel syndrome with constipation
Dermatology whether it's okay to use ORAL ketoconazole for tinea versicolor
Cardiology whether it's okay to use an ARB in patients who have angioedema while on an ACE inhibitor
Anticoagulants more about GI bleeding with Pradaxa (dabigatran)
HIV & AIDS More patients will get Truvada to prevent HIV infection BEFORE exposure
Antidepressants how to choose or switch antidepressants
Vaccines Zostavax II, a new formulation of zoster vaccine that is kept in the refrigerator instead of the freezer